HealthLynked Corp.
HealthLynked Corp. (HLYK) Financial Performance & Income Statement Overview
Analyze HealthLynked Corp. (HLYK) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
HealthLynked Corp. (HLYK) Income Statement & Financial Overview
Review HealthLynked Corp. HLYK income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $618927.00 | $590124.00 | $795078.00 | $1.004M |
| Cost of Revenue | $9261.00 | $31674.00 | $538614.00 | $1.18M |
| Gross Profit | $609666.00 | $558450.00 | $256464.00 | -$178595.00 |
| Gross Profit Ratio | $0.99 | $0.95 | $0.32 | -$0.18 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $994517.00 | $631828.00 | $861469.00 | $999443.00 |
| Operating Expenses | $1.36M | $2.23M | $1.85M | $999443.00 |
| Total Costs & Expenses | $1.37M | $2.26M | $1.87M | $2.18M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $584124.00 | $371174.00 | $415915.00 | $113096.00 |
| Depreciation & Amortization | $28436.00 | $82743.00 | $85262.00 | $86509.00 |
| EBITDA | -$617646.00 | -$1.59M | -$1.05M | -$1.15M |
| EBITDA Ratio | -$1.00 | -$2.69 | -$1.32 | -$1.14 |
| Operating Income | -$748774.00 | -$1.67M | -$1.08M | -$1.18M |
| Operating Income Ratio | -$1.21 | -$2.83 | -$1.36 | -$1.17 |
| Other Income/Expenses (Net) | -$481432.00 | -$301772.00 | -$460947.00 | -$209680.00 |
| Income Before Tax | -$1.23M | -$1.97M | -$1.54M | -$1.39M |
| Income Before Tax Ratio | -$1.99 | -$3.34 | -$1.94 | -$1.38 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$1.23M | -$1.97M | -$1.54M | -$1.39M |
| Net Income Ratio | -$1.99 | -$3.34 | -$1.94 | -$1.38 |
| EPS | -$0.004 | -$0.007 | -$0.005 | -$0.005 |
| Diluted EPS | -$0.004 | -$0.007 | -$0.005 | -$0.005 |
| Weighted Avg Shares Outstanding | $281.54M | $281.95M | $281.79M | $280.48M |
| Weighted Avg Shares Outstanding (Diluted) | $281.54M | $281.95M | $281.79M | $280.48M |
Over the last four quarters, HealthLynked Corp. achieved steady financial progress, growing revenue from $1.004M in Q1 2024 to $618927.00 in Q4 2024. Gross profit stayed firm with margins at 99% in Q4 2024 versus -18% in Q1 2024. Operating income totaled -$748774.00 in Q4 2024, maintaining a -121% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at -$617646.00. Net income rose to -$1.23M, with EPS at -$0.004. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan